Reaction
Glioblastoma Multiforme reporting signals
As of the last recalculation, Glioblastoma Multiforme appears in 837 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is TEMOZOLOMIDE (PRR 229.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Temozolomide | 158 | 229.6 | 231.4 |
| Mercaptopurine | 44 | 66.5 | 66.7 |
| Extended Phenytoin Sodium | 23 | 35.1 | 35.2 |
| Vincristine Sulfate | 33 | 29.1 | 29.1 |
| Irinotecan Hydrochloride | 14 | 27.5 | 27.5 |
| Levetiracetam | 114 | 24.4 | 24.4 |
| Cytarabine | 48 | 21.0 | 21.0 |
| Bevacizumab | 79 | 17.4 | 17.4 |
| Levetiracetam In Sodium Chloride | 48 | 16.3 | 16.3 |
| Levetiracetam Oral | 48 | 16.3 | 16.3 |
| Levetiracetam Injection | 48 | 16.3 | 16.3 |
| Clobazam | 15 | 15.5 | 15.5 |
| Doxorubicin | 44 | 12.9 | 12.9 |
| Brivaracetam | 4 | 11.1 | 11.1 |
| Siponimod | 3 | 8.4 | 8.4 |
| Somatropin | 13 | 4.5 | 4.5 |